TRIAL Holdings.Inc.

As of December 31, 2025, TRIAL Holdings.Inc. carries a market capitalization of 379.41B, placing it among publicly traded companies globally. Its enterprise value stands at 655.16B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

TRIAL Holdings.Inc.'s next confirmed earnings release is scheduled for November 12, 2026.

As of December 31, 2025, TRIAL Holdings.Inc. has 122.39M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, TRIAL Holdings.Inc. maintains a current ratio of 0.39, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, TRIAL Holdings.Inc.'s stock has gained approximately 58.40% over the past 52 weeks. The 50-day moving average sits at 3,786.40, while the 200-day moving average is 3,558.84.

As of December 31, 2025, TRIAL Holdings.Inc. holds 116.40B in cash and equivalents against 388.98B in total debt, resulting in a net debt position of 272.58B. Total book value stands at 128.55B, with working capital of -398.24B providing operational flexibility.